United States Pharmaceuticals

Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics experienced significant selling activity over the past ninety days, totaling approximately 1.6 million dollars in net outflows. Executives and directors executed twenty-nine transactions, exclusively divestments. These sales occurred alongside a recent earnings report that missed expectations, while the stock price remained relatively stable despite the heavy insider liquidation.
Ticker: ARQT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Arcutis Biotherapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Matsuda Masaru EVP, Chief Legal Officer Officer
Transaction date
Planned sale
Price
115.20
Quantity 50,083 +19.8%
Value US$665,078
3.1
Masaru Matsuda Officer Officer
Transaction date
Proposed sale
Price
215.12
Quantity 9,021
Value US$1,261,069
2.4
Burnett Patrick EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
130.35
Quantity 25,600 +42.6%
Value US$4,178,445
3.1
Matsuda Masaru EVP, Chief Legal Officer Officer
Transaction date
Sale
Price
31.86
Quantity 1,000 -1.1%
Value US$100,000
2.5
Watanabe Todd See Remarks Executive Director
Transaction date
Sale
Price
31.86
Quantity 1,000 -0.6%
Value US$100,000
2.5
Todd Franklin Watanabe Officer Officer
Transaction date
Proposed sale
Price
31.86
Quantity 1,000
Value US$100,000
3.1
Masaru Matsuda Officer Officer
Transaction date
Proposed sale
Price
31.86
Quantity 1,000
Value US$100,000
2.4
Patrick Burnett Officer Officer
Transaction date
Proposed sale
Price
31.86
Quantity 1,000
Value US$100,000
2.5
Larry Todd Edwards Former Officer Officer
Transaction date
Proposed sale
Price
33.00
Quantity 1,000
Value US$100,000
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
26.93
Quantity 1,000 -11.8%
Value US$100,000
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
26.93
Quantity 4,728
Value US$127,325
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Planned sale
Price
25.00
Quantity 3,674 -3.2%
Value US$91,853
2.5
Larry Todd Edwards Former Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 341,980
Value US$8,549,500
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
24.18
Quantity 4,730 -11.7%
Value US$114,371
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
24.18
Quantity 4,730
Value US$114,371
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Planned sale
Price
25.03
Quantity 9,989 -7.9%
Value US$249,986
3.1
Masaru Matsuda Officer Officer
Transaction date
Proposed sale
Price
25.03
Quantity 13,663
Value US$341,933
3.1
Curran Terrie Non-Executive Director
Transaction date
Sale
Price
25.03
Quantity 27,052 -53.5%
Value US$677,095
3.1
Curran Terrie Non-Executive Director
Transaction date
Sale
Price
25.03
Quantity 11,148 -32.2%
Value US$279,028
3.1
Terrie Curran Director Non-Executive Director
Transaction date
Proposed sale
Price
25.03
Quantity 38,200
Value US$956,125
3.1
Curran Terrie Non-Executive Director
Transaction date
Sale
Price
26.04
Quantity 1,072 -4.4%
Value US$27,912
3.1
Terrie Curran Director Non-Executive Director
Transaction date
Proposed sale
Price
26.04
Quantity 1,072
Value US$27,912
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
27.00
Quantity 1,697 -1.4%
Value US$45,819
2.4
Patrick Burnett Officer Officer
Transaction date
Proposed sale
Price
27.00
Quantity 1,697
Value US$45,819
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
26.18
Quantity 4,730 -11.5%
Value US$123,835
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
26.18
Quantity 4,730
Value US$123,835
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
26.08
Quantity 6,700 -5.3%
Value US$174,767
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
26.52
Quantity 8,300 -6.5%
Value US$220,129
2.4
Patrick Burnett Officer Officer
Transaction date
Proposed sale
Price
26.52
Quantity 15,000
Value US$397,824
2.5
Watanabe Todd See Remarks Executive Director
Transaction date
Planned sale
Price
26.12
Quantity 4,375 -0.6%
Value US$114,261
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
26.12
Quantity 955 -0.8%
Value US$24,942
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Planned sale
Price
26.12
Quantity 1,230 -1.0%
Value US$32,124
3.1
Matsuda Masaru Officer Officer
Transaction date
Proposed sale
Price
26.12
Quantity 1,230
Value US$32,124
2.5
Todd Frank Watanabe Officer Officer
Transaction date
Proposed sale
Price
26.12
Quantity 4,375
Value US$114,261
2.4
Patrick Burnett Officer Officer
Transaction date
Proposed sale
Price
26.12
Quantity 955
Value US$24,942
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
26.91
Quantity 4,730 -11.3%
Value US$127,284
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
26.91
Quantity 4,730
Value US$127,284
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
25.67
Quantity 635 -1.7%
Value US$16,300
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
25.67
Quantity 635
Value US$16,300
3.0
LIN SUE-JEAN Non-Executive Director
Transaction date
Planned sale
Price
24.38
Quantity 4,946 -15.2%
Value US$120,587
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
24.41
Quantity 4,096 -9.6%
Value US$99,980
3.0
Sue-Jean Lin Officer Officer
Transaction date
Proposed sale
Price
24.38
Quantity 4,946
Value US$120,587
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
24.41
Quantity 4,096
Value US$99,980
3.2
Vairavan Latha SVP Chief Financial Officer Officer
Transaction date
Sale
Price
21.05
Quantity 435 -0.5%
Value US$9,157
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
21.05
Quantity 222 -0.2%
Value US$4,673
2.4
Patrick Burnett Officer Officer
Transaction date
Proposed sale
Price
21.05
Quantity 222
Value US$4,673
3.2
Latha Vairavan officer Officer
Transaction date
Proposed sale
Price
21.05
Quantity 435
Value US$9,157
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Sale
Price
23.61
Quantity 884 -0.7%
Value US$20,872
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Planned sale
Price
23.27
Quantity 7,372 -5.5%
Value US$171,543
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
23.61
Quantity 684 -0.6%
Value US$16,150
3.2
Vairavan Latha SVP Chief Financial Officer Officer
Transaction date
Sale
Price
23.61
Quantity 1,341 -1.5%
Value US$31,662
2.5
Watanabe Todd See Remarks Executive Director
Transaction date
Sale
Price
23.61
Quantity 3,172 -0.4%
Value US$74,893
3.2
Latha Vairavan Officer Officer
Transaction date
Proposed sale
Price
23.61
Quantity 1,341
Value US$31,662
2.4
Patrick Burnett Officer Officer
Transaction date
Proposed sale
Price
23.61
Quantity 684
Value US$16,150
2.5
Todd Watanabe Officer Officer
Transaction date
Proposed sale
Price
23.61
Quantity 3,172
Value US$74,893
3.1
Masaru Matsuda officer Officer
Transaction date
Proposed sale
Price
23.31
Quantity 8,256
Value US$192,416
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
22.99
Quantity 7,144 -18.0%
Value US$164,220
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
22.99
Quantity 7,144
Value US$164,220
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
23.88
Quantity 10,000 -20.1%
Value US$238,801
1.5
Howard Welgus Director Non-Executive Director
Transaction date
Proposed sale
Price
23.88
Quantity 10,000
Value US$238,801
Leonard Keith R Non-Executive Director
Transaction date
Planned sale
Price
25.39
Quantity 39,272 -64.0%
Value US$997,195
1.5
Welgus Howard G. Non-Executive Director
Transaction date
Planned sale
Price
25.65
Quantity 10,000 -16.7%
Value US$256,518
2.5
Watanabe Todd See Remarks Executive Director
Transaction date
Sale
Price
25.91
Quantity 1,068 -0.1%
Value US$27,676
2.5
Watanabe Todd See Remarks Executive Director
Transaction date
Sale
Price
25.16
Quantity 36,281 -4.4%
Value US$912,852
2.5
Edwards Larry Todd See Remarks Officer
Transaction date
Sale
Price
25.91
Quantity 103 -0.1%
Value US$2,669
2.5
Edwards Larry Todd See Remarks Officer
Transaction date
Sale
Price
25.16
Quantity 3,584 -2.0%
Value US$90,177
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
25.91
Quantity 181 -0.1%
Value US$4,690
2.4
Burnett Patrick See Remarks Officer
Transaction date
Sale
Price
25.16
Quantity 6,106 -4.8%
Value US$153,629
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Planned sale
Price
25.70
Quantity 1,987 -1.4%
Value US$51,066
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Sale
Price
25.91
Quantity 193 -0.1%
Value US$5,001
3.1
Matsuda Masaru See Remarks Officer
Transaction date
Sale
Price
25.16
Quantity 6,553 -4.6%
Value US$164,876
3.2
Vairavan Latha SVP Chief Financial Officer Officer
Transaction date
Sale
Price
25.91
Quantity 81 -0.1%
Value US$2,099
3.2
Vairavan Latha SVP Chief Financial Officer Officer
Transaction date
Sale
Price
25.16
Quantity 2,772 -3.1%
Value US$69,745
3.1
Masaru Matsuda officer Officer
Transaction date
Proposed sale
Price
26.03
Quantity 12,058
Value US$313,878
2.5
Larry Todd Edwards Officer Officer
Transaction date
Proposed sale
Price
25.18
Quantity 3,687
Value US$92,846
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-04 2026-11-04 PlS Planned sale
3.1
Matsuda Masaru

EVP, Chief Legal Officer

Officer
50,083 +19.8%
115.20
US$665,078 		50,083 +19.8% 115.20 US$665,078
2026-11-04 2026-11-04 PrS Proposed sale
3.1
Masaru Matsuda

Officer

Officer
9,021
215.12
US$1,261,069 		9,021 215.12 US$1,261,069
2026-11-04 2026-11-02 S Sale
2.4
Burnett Patrick

EVP, Chief Medical Officer

Officer
25,600 +42.6%
130.35
US$4,178,445 		25,600 +42.6% 130.35 US$4,178,445
2026-11-04 2026-11-02 S Sale
3.1
Matsuda Masaru

EVP, Chief Legal Officer

Officer
1,000 -1.1%
31.86
US$100,000 		1,000 -1.1% 31.86 US$100,000
2026-11-04 2026-11-02 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
1,000 -0.6%
31.86
US$100,000 		1,000 -0.6% 31.86 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.5
Todd Franklin Watanabe

Officer

Officer
1,000
31.86
US$100,000 		1,000 31.86 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
3.1
Masaru Matsuda

Officer

Officer
1,000
31.86
US$100,000 		1,000 31.86 US$100,000
2026-11-02 2026-11-02 PrS Proposed sale
2.4
Patrick Burnett

Officer

Officer
1,000
31.86
US$100,000 		1,000 31.86 US$100,000
2026-10-20 2026-10-20 PrS Proposed sale
2.5
Larry Todd Edwards

Former Officer

Officer
1,000
33.00
US$100,000 		1,000 33.00 US$100,000
2026-10-19 2026-10-15 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
1,000 -11.8%
26.93
US$100,000 		1,000 -11.8% 26.93 US$100,000
2026-10-15 2026-10-15 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
4,728
26.93
US$127,325 		4,728 26.93 US$127,325
2026-09-18 2026-09-16 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
3,674 -3.2%
25.00
US$91,853 		3,674 -3.2% 25.00 US$91,853
2026-09-16 2026-09-16 PrS Proposed sale
2.5
Larry Todd Edwards

Former Officer

Officer
341,980
25.00
US$8,549,500 		341,980 25.00 US$8,549,500
2026-09-17 2026-09-15 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
4,730 -11.7%
24.18
US$114,371 		4,730 -11.7% 24.18 US$114,371
2026-09-15 2026-09-15 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
4,730
24.18
US$114,371 		4,730 24.18 US$114,371
2026-09-10 2026-09-08 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
9,989 -7.9%
25.03
US$249,986 		9,989 -7.9% 25.03 US$249,986
2026-09-08 2026-09-08 PrS Proposed sale
3.1
Masaru Matsuda

Officer

Officer
13,663
25.03
US$341,933 		13,663 25.03 US$341,933
2026-08-28 2026-08-27 S Sale
3.1
Curran Terrie
Non-Executive Director
27,052 -53.5%
25.03
US$677,095 		27,052 -53.5% 25.03 US$677,095
2026-08-28 2026-08-27 S Sale
3.1
Curran Terrie
Non-Executive Director
11,148 -32.2%
25.03
US$279,028 		11,148 -32.2% 25.03 US$279,028
2026-08-27 2026-08-27 PrS Proposed sale
3.1
Terrie Curran

Director

Non-Executive Director
38,200
25.03
US$956,125 		38,200 25.03 US$956,125
2026-08-24 2026-08-20 S Sale
3.1
Curran Terrie
Non-Executive Director
1,072 -4.4%
26.04
US$27,912 		1,072 -4.4% 26.04 US$27,912
2026-08-20 2026-08-20 PrS Proposed sale
3.1
Terrie Curran

Director

Non-Executive Director
1,072
26.04
US$27,912 		1,072 26.04 US$27,912
2026-08-21 2026-08-19 S Sale
2.4
Burnett Patrick

See Remarks

Officer
1,697 -1.4%
27.00
US$45,819 		1,697 -1.4% 27.00 US$45,819
2026-08-19 2026-08-19 PrS Proposed sale
2.4
Patrick Burnett

Officer

Officer
1,697
27.00
US$45,819 		1,697 27.00 US$45,819
2026-08-19 2026-08-17 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
4,730 -11.5%
26.18
US$123,835 		4,730 -11.5% 26.18 US$123,835
2026-08-17 2026-08-17 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
4,730
26.18
US$123,835 		4,730 26.18 US$123,835
2026-08-13 2026-08-12 S Sale
2.4
Burnett Patrick

See Remarks

Officer
6,700 -5.3%
26.08
US$174,767 		6,700 -5.3% 26.08 US$174,767
2026-08-13 2026-08-11 S Sale
2.4
Burnett Patrick

See Remarks

Officer
8,300 -6.5%
26.52
US$220,129 		8,300 -6.5% 26.52 US$220,129
2026-08-11 2026-08-11 PrS Proposed sale
2.4
Patrick Burnett

Officer

Officer
15,000
26.52
US$397,824 		15,000 26.52 US$397,824
2026-08-05 2026-08-03 PlS Planned sale
2.5
Watanabe Todd

See Remarks

Executive Director
4,375 -0.6%
26.12
US$114,261 		4,375 -0.6% 26.12 US$114,261
2026-08-05 2026-08-03 S Sale
2.4
Burnett Patrick

See Remarks

Officer
955 -0.8%
26.12
US$24,942 		955 -0.8% 26.12 US$24,942
2026-08-05 2026-08-03 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
1,230 -1.0%
26.12
US$32,124 		1,230 -1.0% 26.12 US$32,124
2026-08-03 2026-08-03 PrS Proposed sale
3.1
Matsuda Masaru

Officer

Officer
1,230
26.12
US$32,124 		1,230 26.12 US$32,124
2026-08-03 2026-08-03 PrS Proposed sale
2.5
Todd Frank Watanabe

Officer

Officer
4,375
26.12
US$114,261 		4,375 26.12 US$114,261
2026-08-03 2026-08-03 PrS Proposed sale
2.4
Patrick Burnett

Officer

Officer
955
26.12
US$24,942 		955 26.12 US$24,942
2026-07-17 2026-07-15 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
4,730 -11.3%
26.91
US$127,284 		4,730 -11.3% 26.91 US$127,284
2026-07-15 2026-07-15 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
4,730
26.91
US$127,284 		4,730 26.91 US$127,284
2026-06-17 2026-06-17 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
635 -1.7%
25.67
US$16,300 		635 -1.7% 25.67 US$16,300
2026-06-17 2026-06-17 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
635
25.67
US$16,300 		635 25.67 US$16,300
2026-06-17 2026-06-15 PlS Planned sale
3.0
LIN SUE-JEAN
Non-Executive Director
4,946 -15.2%
24.38
US$120,587 		4,946 -15.2% 24.38 US$120,587
2026-06-17 2026-06-15 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
4,096 -9.6%
24.41
US$99,980 		4,096 -9.6% 24.41 US$99,980
2026-06-15 2026-06-15 PrS Proposed sale
3.0
Sue-Jean Lin

Officer

Officer
4,946
24.38
US$120,587 		4,946 24.38 US$120,587
2026-06-15 2026-06-15 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
4,096
24.41
US$99,980 		4,096 24.41 US$99,980
2026-05-13 2026-05-11 S Sale
3.2
Vairavan Latha

SVP Chief Financial Officer

Officer
435 -0.5%
21.05
US$9,157 		435 -0.5% 21.05 US$9,157
2026-05-13 2026-05-11 S Sale
2.4
Burnett Patrick

See Remarks

Officer
222 -0.2%
21.05
US$4,673 		222 -0.2% 21.05 US$4,673
2026-05-11 2026-05-11 PrS Proposed sale
2.4
Patrick Burnett

Officer

Officer
222
21.05
US$4,673 		222 21.05 US$4,673
2026-05-11 2026-05-11 PrS Proposed sale
3.2
Latha Vairavan

officer

Officer
435
21.05
US$9,157 		435 21.05 US$9,157
2026-05-06 2026-05-04 S Sale
3.1
Matsuda Masaru

See Remarks

Officer
884 -0.7%
23.61
US$20,872 		884 -0.7% 23.61 US$20,872
2026-05-06 2026-05-04 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
7,372 -5.5%
23.27
US$171,543 		7,372 -5.5% 23.27 US$171,543
2026-05-06 2026-05-04 S Sale
2.4
Burnett Patrick

See Remarks

Officer
684 -0.6%
23.61
US$16,150 		684 -0.6% 23.61 US$16,150
2026-05-06 2026-05-04 S Sale
3.2
Vairavan Latha

SVP Chief Financial Officer

Officer
1,341 -1.5%
23.61
US$31,662 		1,341 -1.5% 23.61 US$31,662
2026-05-06 2026-05-04 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
3,172 -0.4%
23.61
US$74,893 		3,172 -0.4% 23.61 US$74,893
2026-05-04 2026-05-04 PrS Proposed sale
3.2
Latha Vairavan

Officer

Officer
1,341
23.61
US$31,662 		1,341 23.61 US$31,662
2026-05-04 2026-05-04 PrS Proposed sale
2.4
Patrick Burnett

Officer

Officer
684
23.61
US$16,150 		684 23.61 US$16,150
2026-05-04 2026-05-04 PrS Proposed sale
2.5
Todd Watanabe

Officer

Officer
3,172
23.61
US$74,893 		3,172 23.61 US$74,893
2026-05-04 2026-05-04 PrS Proposed sale
3.1
Masaru Matsuda

officer

Officer
8,256
23.31
US$192,416 		8,256 23.31 US$192,416
2026-05-05 2026-05-01 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
7,144 -18.0%
22.99
US$164,220 		7,144 -18.0% 22.99 US$164,220
2026-05-01 2026-05-01 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
7,144
22.99
US$164,220 		7,144 22.99 US$164,220
2026-04-03 2026-04-01 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
10,000 -20.1%
23.88
US$238,801 		10,000 -20.1% 23.88 US$238,801
2026-04-01 2026-04-01 PrS Proposed sale
1.5
Howard Welgus

Director

Non-Executive Director
10,000
23.88
US$238,801 		10,000 23.88 US$238,801
2026-03-04 2026-03-02 PlS Planned sale
Leonard Keith R
Non-Executive Director
39,272 -64.0%
25.39
US$997,195 		39,272 -64.0% 25.39 US$997,195
2026-03-04 2026-03-02 PlS Planned sale
1.5
Welgus Howard G.
Non-Executive Director
10,000 -16.7%
25.65
US$256,518 		10,000 -16.7% 25.65 US$256,518
2026-03-03 2026-03-02 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
1,068 -0.1%
25.91
US$27,676 		1,068 -0.1% 25.91 US$27,676
2026-03-03 2026-03-02 S Sale
2.5
Watanabe Todd

See Remarks

Executive Director
36,281 -4.4%
25.16
US$912,852 		36,281 -4.4% 25.16 US$912,852
2026-03-03 2026-03-02 S Sale
2.5
Edwards Larry Todd

See Remarks

Officer
103 -0.1%
25.91
US$2,669 		103 -0.1% 25.91 US$2,669
2026-03-03 2026-03-02 S Sale
2.5
Edwards Larry Todd

See Remarks

Officer
3,584 -2.0%
25.16
US$90,177 		3,584 -2.0% 25.16 US$90,177
2026-03-03 2026-03-02 S Sale
2.4
Burnett Patrick

See Remarks

Officer
181 -0.1%
25.91
US$4,690 		181 -0.1% 25.91 US$4,690
2026-03-03 2026-03-02 S Sale
2.4
Burnett Patrick

See Remarks

Officer
6,106 -4.8%
25.16
US$153,629 		6,106 -4.8% 25.16 US$153,629
2026-03-03 2026-03-02 PlS Planned sale
3.1
Matsuda Masaru

See Remarks

Officer
1,987 -1.4%
25.70
US$51,066 		1,987 -1.4% 25.70 US$51,066
2026-03-03 2026-03-02 S Sale
3.1
Matsuda Masaru

See Remarks

Officer
193 -0.1%
25.91
US$5,001 		193 -0.1% 25.91 US$5,001
2026-03-03 2026-03-02 S Sale
3.1
Matsuda Masaru

See Remarks

Officer
6,553 -4.6%
25.16
US$164,876 		6,553 -4.6% 25.16 US$164,876
2026-03-03 2026-03-02 S Sale
3.2
Vairavan Latha

SVP Chief Financial Officer

Officer
81 -0.1%
25.91
US$2,099 		81 -0.1% 25.91 US$2,099
2026-03-03 2026-03-02 S Sale
3.2
Vairavan Latha

SVP Chief Financial Officer

Officer
2,772 -3.1%
25.16
US$69,745 		2,772 -3.1% 25.16 US$69,745
2026-03-02 2026-03-02 PrS Proposed sale
3.1
Masaru Matsuda

officer

Officer
12,058
26.03
US$313,878 		12,058 26.03 US$313,878
2026-03-02 2026-03-02 PrS Proposed sale
2.5
Larry Todd Edwards

Officer

Officer
3,687
25.18
US$92,846 		3,687 25.18 US$92,846

See older Arcutis Biotherapeutics, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Arcutis Biotherapeutics, Inc. history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Arcutis Biotherapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America